Post by
biggdogg on Dec 14, 2023 11:53am
sales
This is good news, for a distribution company to sign a deal with Voy means their product launch is imminent, no one signs a deal unless they know they are going to be supplied. There will now be many distribution companies signing deals in the future. They must be close to getting all 5 products tested and ready for market. The set back with the FDA of change of classification to a drug, in February of this year, will not stop them from moving forward. The monopoly will have two choices, loose market share or buy them out. What happens to the monopoly when customers switch to Voyageur barium? They no longer buy any of their other products such as iodine and gadolinium. Losing barium customers has a much deeper impact on the monopoly than just barium sales. Go Voyageur! Get more deals in place, this is what we have been waiting for!!
Comment by
whitenorth72 on Dec 14, 2023 3:23pm
When the first official deal is secured this will merit their business plan and the PEA takes hold. FDA approval should follow when funds are secured because Barium is a Critical mineral in the states. Canada has dropped the ball by not including this mineral (probably because it didn't fit in the maple leaf design) but will soon regret it if a buyout does become a reality.